CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($) $ in Thousands	Total	Common Stock	Paid-in Capital	Retained Earnings	Accumulated Other Comprehensive Loss	Treasury Stock	Nonredeemable Noncontrolling Interests	Cumulative Effect, Period of Adoption, Adjustment	Cumulative Effect, Period of Adoption, Adjustment Retained Earnings	Cumulative Effect, Period of Adoption, Adjustment Accumulated Other Comprehensive Loss
Balance at beginning of period (in shares) at Feb. 03, 2018		81,371,118				60,252,569
Balance at beginning of period at Feb. 03, 2018	$ 933,475	$ 813	$ 498,249	$ 1,132,173	$ (93,062)	$ (621,354)	$ 16,656	$ 5,829	$ 5,829
Increase (Decrease) in Stockholders' Equity
Net earnings (loss)	17,166			14,099			3,067
Other comprehensive income (loss)	(33,353)				(33,117)		(236)
Issuance of common stock under stock compensation plans including tax effect (in shares)		1,083,613
Issuance of common stock under stock compensation plans including tax effect	5,006	$ 12	4,994
Issuance of stock under Employee Stock Purchase Plan (in shares)		43,737				(43,737)
Issuance of stock under Employee Stock Purchase Plan	738		283			$ 455
Share-based compensation	19,973		19,794	179
Dividends	(74,533)			(74,533)
Share repurchases (in shares)		(1,118,808)				1,118,808
Share repurchases	(17,587)	$ (11)	11			$ (17,587)
Noncontrolling interest capital distribution	(3,069)						(3,069)
Balance at end of period (in shares) at Feb. 02, 2019		81,379,660				61,327,640
Balance at end of period at Feb. 02, 2019	853,645	$ 814	523,331	1,077,747	(126,179)	$ (638,486)	16,418	$ 297	(1,684)	$ 1,981
Increase (Decrease) in Stockholders' Equity
Net earnings (loss)	101,229			95,975			5,254
Other comprehensive income (loss)	(15,083)				(15,712)		629
Issuance of common stock under stock compensation plans including tax effect (in shares)		1,155,166				(994,519)
Issuance of common stock under stock compensation plans including tax effect	2,801	$ 10	(8,699)			$ 11,490
Issuance of stock under Employee Stock Purchase Plan (in shares)		53,424				(53,424)
Issuance of stock under Employee Stock Purchase Plan	783	$ 1	166			$ 616
Share-based compensation	24,290		24,079	211
Dividends	(41,840)			(41,840)
Share repurchases (in shares)		(16,739,740)				16,739,740
Share repurchases	(288,067)	$ (167)	167			$ (288,067)
Noncontrolling interest capital distribution	(668)						(668)
Equity component value of convertible note issuance, net	42,320		42,320
Sale of common stock warrant	28,080		28,080
Purchase of convertible note hedge	$ (46,440)		(46,440)
Balance at end of period (in shares) at Feb. 01, 2020	65,848,510	65,848,510				77,019,437
Balance at end of period at Feb. 01, 2020	$ 661,347	$ 658	563,004	1,130,409	(139,910)	$ (914,447)	21,633		$ 2,000
Increase (Decrease) in Stockholders' Equity
Net earnings (loss)	(80,741)			(81,229)			488
Other comprehensive income (loss)	19,031				19,235		(204)
Issuance of common stock under stock compensation plans including tax effect (in shares)		2,294,872				(2,369,140)
Issuance of common stock under stock compensation plans including tax effect	(185)	$ 24	(28,267)			$ 28,058
Issuance of stock under Employee Stock Purchase Plan (in shares)		86,780				(86,780)
Issuance of stock under Employee Stock Purchase Plan	600	$ 0	(427)			$ 1,027
Share-based compensation	18,830		18,761	69
Dividends	(14,426)			(14,426)
Share repurchases (in shares)		(4,000,000)				4,000,000
Share repurchases	$ (38,876)	$ (40)	40			$ (38,876)
Balance at end of period (in shares) at Jan. 30, 2021	64,230,162	64,230,162				78,563,517
Balance at end of period at Jan. 30, 2021	$ 565,580	$ 642	$ 553,111	$ 1,034,823	$ (120,675)	$ (924,238)	$ 21,917